iMM - Instituto de Medicina Molecular

The Instituto de Medicina Molecular (iMM) is a leading Portuguese private non-profit research institute that offers a vibrant scientific environment, aiming to nurture innovative ideas in basic, clinical and translational Biomedical Research. The iMM’s mission is to improve human health through the study of disease mechanisms and the development of novel diagnostic tests and therapeutic approaches. Created in 2002, with the vision to achieve a world-class research portfolio focusing on innovative conceptual niches from the molecule to the bedside, iMM is an institute where science meets medicine. The overall strategy has been defined by promotion of excellence, leveraged by high-quality human resources, increasing expenditure in infrastructures and knowledge transfer to the society. iMM has gathered a strong scientific critical mass, with 33 group leaders, 202 PhD researchers, 82 PhD students and 121 technical and administrative collaborators.

Website  | Facebook  | Linkedin

Institut Curie

The Institut Curie is a private non-profit organization created in 1909, on a model devised by Marie Curie and still at the cutting edge: "from fundamental research to innovative treatments". Institut Curie is a cancer foundation and comprises of a research centre and a hospital dedicated entirely to the care of cancer patients. Total personnel amounts up to 2000 persons in the Hospitals (3 sites) and 1110 persons in the Research Centre (2 sites). It is the largest European oncology research centre with two state-of-the-art hospitals. The Research Centre consists of 14 research units located in Paris and Orsay and gathers about 300 staff scientist, 178 PhD students (45% from abroad), 216 postdoctoral fellows (from 67 nationalities), 400 engineers, technicians and administrative officers. 


DKFZ – Deutsches Krebsforschungszentrum

The German Cancer Research Centre (DKFZ) is the largest biomedical research institute in Germany. The strategic goals of the DKFZ are to contribute towards a better understanding of fundamental processes in cancer and to develop innovative methods of cancer diagnostics and therapy. Established in 1964, the DKFZ has today more than 1,000 scientists that investigate how cancer develops, identify cancer risk factors and endeavor to find new strategies to prevent people from getting cancer. The staff of the Cancer Information Service (KID) offers information about the widespread disease of cancer for patients, their families, and the general public. Jointly with Heidelberg University Hospital, DKFZ has established the National Center for Tumor Diseases (NCT) Heidelberg, where promising approaches from cancer research are translated into the clinic. DKFZ is a member of the Helmholtz Association of National Research Centers, with 90% of its funding coming from the German Federal Ministry of Education and Research and the remaining ten percent from the State of Baden-Württemberg.

Website  | Facebook